Enfusion (ENFN) Insider Trading & Ownership $8.77 +0.19 (+2.21%) (As of 07/5/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enfusion (NYSE:ENFN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage36.44%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$23.66 M ENFN Insider Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Enfusion Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/20/2024Bronwen BastoneInsiderSell18,241$8.11$147,934.51 6/18/2024Bronwen BastoneInsiderSell10,539$8.17$86,103.63 6/18/2024Matthew CampobassoGeneral CounselSell1,651$8.17$13,488.67 6/18/2024Valeria GutowskiCAOSell1,258$8.17$10,277.86 6/14/2024Deirdre SomersDirectorSell4,629$8.40$38,883.60 2/29/2024Matthew CampobassoGeneral CounselSell108$8.73$942.84 [Urgent] Hedge Funds Expect Major Crypto Moves (Ad)In the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… Click here to register now.2/29/2024Valeria GutowskiCAOSell27$8.73$235.71 1/10/2024Deirdre SomersDirectorSell1,770$8.65$15,310.50 1/8/2024Bradley HerringCFOSell1,998$9.23$18,441.54 1/8/2024Bronwen BastoneInsiderSell391$9.23$3,608.93 1/8/2024Matthew CampobassoGeneral CounselSell472$9.23$4,356.56 1/8/2024Oleg MovchanCEOSell1,295$9.23$11,952.85 12/14/2023Oleg MovchanCEOSell100,000$10.01$1,001,000.00 12/1/2023Oleg MovchanCEOSell150,000$10.09$1,513,500.00 11/27/2023Stephen MalherbeMajor ShareholderSell1,000,000$9.86$9,860,000.00 11/14/2023Dan GromanCTOSell5,000$9.97$49,850.00 10/17/2023Dan GromanCTOSell5,000$9.09$45,450.00 9/19/2023Dan GromanCTOSell5,000$9.07$45,350.00 8/14/2023Bronwen BastoneInsiderSell41$7.89$323.49 8/14/2023Dan GromanCTOSell1,760$7.89$13,886.40 8/11/2023Bronwen BastoneInsiderSell44$8.10$356.40 8/11/2023Dan GromanCTOSell1,850$8.10$14,985.00 8/9/2023Bronwen BastoneInsiderSell55$8.32$457.60 8/9/2023Dan GromanCTOSell2,317$8.32$19,277.44 7/17/2023Dan GromanCTOSell3,877$11.31$43,848.87 7/11/2023Tarek HammoudMajor ShareholderSell1,000,000$10.70$10,700,000.00 (Data available from 1/1/2013 forward) ENFN Insider Trading Activity - Frequently Asked Questions Who is on Enfusion's Insider Roster? The list of insiders at Enfusion includes Bradley Herring, Bronwen Bastone, Dan Groman, Deirdre Somers, Hillhouse Investment Managemen, Matthew Campobasso, Oleg Movchan, Roy Luo, Stephen Malherbe, Tarek Hammoud, and Valeria Gutowski. Learn more on insiders at ENFN. What percentage of Enfusion stock is owned by insiders? 36.44% of Enfusion stock is owned by insiders. Learn more on ENFN's insider holdings. Which Enfusion insiders have been selling company stock? The following insiders have sold ENFN shares in the last 24 months: Bradley Herring ($18,441.54), Bronwen Bastone ($238,784.56), Dan Groman ($514,740.06), Deirdre Somers ($54,194.10), Matthew Campobasso ($18,788.07), Oleg Movchan ($2,526,452.85), Stephen Malherbe ($21,210,000.00), Tarek Hammoud ($22,850,000.00), and Valeria Gutowski ($10,513.57). How much insider selling is happening at Enfusion? Insiders have sold a total of 4,347,879 Enfusion shares in the last 24 months for a total of $47,441,914.75 sold. More Insider Trading Tools from MarketBeat Related Companies: ACI Worldwide Insider Transactions Workiva Insider Transactions Braze Insider Transactions Blackbaud Insider Transactions Zeta Global Insider Transactions JFrog Insider Transactions BOX Insider Transactions Freshworks Insider Transactions Q2 Insider Transactions nCino Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, TreaceIs CAVA Overextended? A Closer Look at This High-Flying StockOccidental Petroleum: Buffett Causes OXY Stock Rebound3 Tech Stocks Insiders, Major Shareholders, and Institutions BuyThe Top 3 Stocks Sold by Insiders This Quarter This page (NYSE:ENFN) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...All American Assets | Sponsored50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Enfusion, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.